Other publications in Journal of biological response modifiers

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenoca...

Published in Dec 01, 1990

Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interfer...

Published in Dec 01, 1990

A phase I study of high-dose interleukin-2 in combination with interferon-alpha 2b.

Published in Dec 01, 1990

Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo...

Published in Dec 01, 1990

Effects of granulocyte colony-stimulating factor on hematopoietic injury induced by anticancer drugs...

Published in Dec 01, 1990